This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Benzinga·3d ago
Share
Listen to the news
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Baird analyst David Rescott initiated coverage on Abbott Laboratories(NYSE:ABT) with an Outperform rating and announced a price target of $121. Abbott shares closed at $90.74 on Tuesday. See how other analysts view this stock.
Freedom Capital Markets analyst Keith Hinton initiated coverage on LivaNova PLC(NASDAQ:LIVN) with a Hold rating and announced a price target of $81. LivaNova shares closed at $82.23 on Tuesday. See how other analysts view this stock.
Raymond James analyst Mark Cash initiated coverage on Amplitude Inc(NASDAQ:AMPL) with a Strong Buy rating and announced a price target of $10. Amplitude shares closed at $7.65 on Tuesday. See how other analysts view this stock.
B. Riley Securities analyst Drew Crum initiated coverage on Lionsgate Studios Corp(NYSE:LION) with a Neutral rating and announced a price target of $17. Lionsgate Studios shares closed at $15.31 on Tuesday. See how other analysts view this stock.
Wells Fargo analyst David Strauss initiated coverage on Honeywell Aerospace Inc(NASDAQ:HONA) with an Equal-Weight rating and announced a price target of $250. Honeywell Aerospace shares closed at $221.08 on Tuesday. See how other analysts view this stock.
Considering buying ABT stock? Here’s what analysts think:
Photo via Shutterstock
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.